Omnicell (OMCL) Other Non-Current Liabilities (2010 - 2026)
Omnicell's (OMCL) quarterly Other Non-Current Liabilities came in at $11.1 million in Q2 2026, up 39.82% year-over-year from $8.0 million in Q2 2025, and up 9.64% quarter-over-quarter from $10.2 million in Q1 2026.
Analysis
Omnicell (OMCL) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Other Non-Current Liabilities for 17 consecutive years, with $11.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 39.82% year-over-year to $11.1 million in Q2 2026; TTM through Jun 2026 was $11.1 million, a 39.82% increase from a year earlier, with the FY2025 full-year figure at $10.0 million, up 38.13% from the prior year.
- Other Non-Current Liabilities was $11.1 million for Q2 2026 at Omnicell, up from $10.2 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $11.1 million in Q2 2026 and troughed at $6.1 million in Q1 2023.
- A 5-year average of $7.9 million and a median of $7.5 million in 2024 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities slumped 60.35% in 2022 and soared 39.82% in 2026, its largest moves.
- Over 5 years, Other Non-Current Liabilities stood at $6.7 million in 2022, then decreased by 5.97% to $6.3 million in 2023, then gained by 14.25% to $7.2 million in 2024, then soared by 38.13% to $10.0 million in 2025, then gained by 11.79% to $11.1 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $11.1 million (Q2 2026), $10.2 million (Q1 2026), and $10.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.15 Mn |
| Mar 31, 2026 | 10.17 Mn |
| Dec 31, 2025 | 9.97 Mn |
| Sep 30, 2025 | 8.23 Mn |
| Jun 30, 2025 | 7.97 Mn |
| Mar 31, 2025 | 7.58 Mn |
| Dec 31, 2024 | 7.22 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | 7.51 Mn |
| Mar 31, 2024 | 7.10 Mn |
| Dec 31, 2023 | 6.32 Mn |
| Sep 30, 2023 | 6.43 Mn |
| Jun 30, 2023 | 6.27 Mn |
| Mar 31, 2023 | 6.14 Mn |
| Dec 31, 2022 | 6.72 Mn |
| Sep 30, 2022 | 9.29 Mn |
| Jun 30, 2022 | 8.81 Mn |
| Mar 31, 2022 | 7.35 Mn |
| Dec 31, 2021 | 7.84 Mn |
| Sep 30, 2021 | 10.76 Mn |